Thrivent Financial for Lutherans’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $621K | Sell |
27,036
-511
| -2% | -$11.7K | ﹤0.01% | 2041 |
|
2025
Q1 | $799K | Sell |
27,547
-1,441
| -5% | -$41.8K | ﹤0.01% | 1854 |
|
2024
Q4 | $1.08M | Sell |
28,988
-827
| -3% | -$30.7K | ﹤0.01% | 1850 |
|
2024
Q3 | $1.45M | Sell |
29,815
-1,850
| -6% | -$89.8K | ﹤0.01% | 1672 |
|
2024
Q2 | $1.27M | Sell |
31,665
-752
| -2% | -$30.1K | ﹤0.01% | 1708 |
|
2024
Q1 | $1.42M | Sell |
32,417
-880
| -3% | -$38.6K | ﹤0.01% | 1669 |
|
2023
Q4 | $2.06M | Sell |
33,297
-30,633
| -48% | -$1.89M | ﹤0.01% | 1350 |
|
2023
Q3 | $2.94M | Sell |
63,930
-24,201
| -27% | -$1.11M | 0.01% | 1044 |
|
2023
Q2 | $5.07M | Buy |
88,131
+50,772
| +136% | +$2.92M | 0.01% | 845 |
|
2023
Q1 | $1.4M | Sell |
37,359
-1,310
| -3% | -$49.1K | ﹤0.01% | 1570 |
|
2022
Q4 | $1.08M | Sell |
38,669
-852
| -2% | -$23.9K | ﹤0.01% | 1681 |
|
2022
Q3 | $1.11M | Buy |
39,521
+2,581
| +7% | +$72.6K | ﹤0.01% | 1622 |
|
2022
Q2 | $1.29M | Buy |
36,940
+6,946
| +23% | +$242K | ﹤0.01% | 1539 |
|
2022
Q1 | $1.08M | Buy |
29,994
+10
| +0% | +$359 | ﹤0.01% | 1781 |
|
2021
Q4 | $698K | Buy |
29,984
+89
| +0.3% | +$2.07K | ﹤0.01% | 2054 |
|
2021
Q3 | $568K | Sell |
29,895
-90
| -0.3% | -$1.71K | ﹤0.01% | 2133 |
|
2021
Q2 | $604K | Sell |
29,985
-63
| -0.2% | -$1.27K | ﹤0.01% | 2109 |
|
2021
Q1 | $550K | Sell |
30,048
-229
| -0.8% | -$4.19K | ﹤0.01% | 2195 |
|
2020
Q4 | $609K | Sell |
30,277
-42
| -0.1% | -$845 | ﹤0.01% | 2041 |
|
2020
Q3 | $568K | Buy |
30,319
+2,091
| +7% | +$39.2K | ﹤0.01% | 1897 |
|
2020
Q2 | $634K | Sell |
28,228
-489
| -2% | -$11K | ﹤0.01% | 1791 |
|
2020
Q1 | $426K | Buy |
28,717
+1,434
| +5% | +$21.3K | ﹤0.01% | 1803 |
|
2019
Q4 | $526K | Sell |
27,283
-109
| -0.4% | -$2.1K | ﹤0.01% | 1869 |
|
2019
Q3 | $543K | Sell |
27,392
-175
| -0.6% | -$3.47K | ﹤0.01% | 1791 |
|
2019
Q2 | $582K | Buy |
27,567
+1,141
| +4% | +$24.1K | ﹤0.01% | 1733 |
|
2019
Q1 | $540K | Buy |
26,426
+2,027
| +8% | +$41.4K | ﹤0.01% | 1762 |
|
2018
Q4 | $486K | Sell |
24,399
-663
| -3% | -$13.2K | ﹤0.01% | 1591 |
|
2018
Q3 | $482K | Buy |
25,062
+440
| +2% | +$8.46K | ﹤0.01% | 1698 |
|
2018
Q2 | $376K | Buy |
24,622
+1,750
| +8% | +$26.7K | ﹤0.01% | 1818 |
|
2018
Q1 | $429K | Buy |
22,872
+572
| +3% | +$10.7K | ﹤0.01% | 1716 |
|
2017
Q4 | $429K | Buy |
22,300
+440
| +2% | +$8.47K | ﹤0.01% | 1760 |
|
2017
Q3 | $391K | Buy |
21,860
+250
| +1% | +$4.47K | ﹤0.01% | 1679 |
|
2017
Q2 | $386K | Buy |
21,610
+1,460
| +7% | +$26.1K | ﹤0.01% | 1652 |
|
2017
Q1 | $292K | Buy |
20,150
+710
| +4% | +$10.3K | ﹤0.01% | 1754 |
|
2016
Q4 | $358K | Buy |
19,440
+400
| +2% | +$7.37K | ﹤0.01% | 1647 |
|
2016
Q3 | $361K | Buy |
+19,040
| New | +$361K | ﹤0.01% | 1630 |
|